TREGA BIOSCIENCES INC
10-Q, EX-27.1, 2000-08-14
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: TREGA BIOSCIENCES INC, 10-Q, EX-10.4, 2000-08-14
Next: REVLON INC /DE/, 10-Q, 2000-08-14



<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM CONSOLIDATED
BALANCE SHEET AT JUNE 30, 2000 AND CONSOLIDATED STATEMENT OF OPERATIONS FOR SIX
MONTH ENDED JUNE 30, 2000, AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH
FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               JUN-30-2000
<CASH>                                           6,018
<SECURITIES>                                     3,700
<RECEIVABLES>                                    1,481
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                12,330
<PP&E>                                           8,952
<DEPRECIATION>                                   4,707
<TOTAL-ASSETS>                                  25,439
<CURRENT-LIABILITIES>                            7,347
<BONDS>                                              0
                                0
                                          0
<COMMON>                                            23
<OTHER-SE>                                      15,161
<TOTAL-LIABILITY-AND-EQUITY>                    25,439
<SALES>                                             44
<TOTAL-REVENUES>                                 4,637
<CGS>                                              107
<TOTAL-COSTS>                                   13,003
<OTHER-EXPENSES>                                   340
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                 265
<INCOME-PRETAX>                                (7,448)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                            (7,448)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   (7,448)
<EPS-BASIC>                                      (.35)
<EPS-DILUTED>                                    (.35)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission